• Ozempic is given as an injection once a week. Doctors in India can now prescribe it for patients with type 2 diabetes. It is considered the primary treatment, but it is very important that patients follow a diet and exercise regimen while taking this drug.
• Ozempic effectively lowers blood sugar and clinical studies have shown that it helps diabetic patients who take it to achieve a healthy weight.
• In addition to the effective benefits of HbA1C control and weight loss, Ozempic may help reduce the risk of cardiovascular disease (such as heart attack and stroke) and kidney problems in adults with type 2 diabetes.

Global healthcare company Novo Nordisk has announced the launch of Ozempic (injectable semaglutide) in India. It is for adults with type 2 diabetes whose diabetes is not controlled with diet and exercise alone. Ozempic is given once a week. It belongs to the GLP-1 RA (glucagon-like peptide-1 receptor agonist) class of drugs. This medicine should be taken as an adjunct to a balanced diet and regular exercise, which are the mainstays of treatment for type 2 diabetes.

In India Ozempic is coming at the right time. According to World Health Organization estimates for 2023-24, 101 million people in India (approximately 11.4% of India’s total population) will suffer from diabetes. After China, India has the second largest diabetes population in the world. Moreover, 136 million people in the country are suffering from pre-diabetes and 254 million people are suffering from moderate obesity. These figures represent a rapidly growing health crisis that requires evidence-based, effective treatments.

A boon for the skin, coconut oil will eliminate facial wrinkles; Learn the correct method of use

Clinical Benefits of Ozempic:

• This drug has been proven to reduce HbA1c levels in the body very effectively. It also significantly promotes weight loss. Both of these effects together contribute to improving a person’s overall metabolic health.
• It is suitable for adults with HbA1c levels of 7% or higher, as well as those at risk of heart disease or who already have heart disease.
• Heart disease is a major concern in people with type 2 diabetes; This medicine helps to reduce the chances of heart disease significantly.
• This drug prevents the progression of kidney disease and helps patients live longer, healthier lives.

Mr. Vikrant Shrotriya, Managing Director, Novo Nordisk India said, “Bringing Ozempic® to India is an important milestone. With global trust, proven clinical excellence and world-class quality, along with a strong supply chain, Ozempic provides effective treatment options to Indian physicians. We aim to provide patients with an innovative and accessible therapy, which provides improved glycemic control, better weight management and long-term cardiovascular and renal protection. It is delivered through a simple, easy-to-use pen device. This once-weekly medication is a reflection of Novo Nordisk’s long-term commitment to improved health outcomes and maintenance of chronic diseases.”

How does Ozempic work?

Ozempic is a GLP-1 receptor agonist that helps:

• Improves glycemic control and lowers HbA1c
• Controls appetite and food intake by acting on the parts of the brain that control appetite
• Helps in weight loss in people with type 2 diabetes (T2DM).
• Reduces the risk of diabetes- heart and kidney complications.

Its once-weekly dosing and globally reliable safety profile have made it a preferred treatment option in clinical practice in many countries.

Calcium Foods: 5 foods that will fill the bones with calcium, wounds will heal quickly; Arthritis disappears in the cold

Ozempic is an original GLP-1 RA (semaglutide) therapy. Novo Nordisk has researched and developed it for over 20 years. It has been clinically used for more than 38 million patient-years worldwide. Semaglutide has recently been included in the World Health Organization Model List of Essential Medicines. This case clearly demonstrates the proven health benefits of this innovative treatment for people with diabetes and obesity.

Ozempic is now available in India as a FlexTouch Pen in dosages of 0.25 mg, 0.5 mg and 1 mg. It is an easy-to-use, once-a-week pen device. These different dosage strengths allow dosages to be taken as directed by the doctor and help in the long-term treatment of diabetes.